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Abstract
Background: Progress in oncology could improve survival rate in children, but would probably lead to impaired fertility and
puberty. In pre-pubertal girls, the only therapeutic option is the cryopreservation of one ovary. Three births have been
reported after reimplantation of cryopreserved mature ovary. Conversely, reimplantation of ovary preserved before puberty
(defined as immature ovary) has never been performed in humans.
Methodology/Principal Findings: In order to analyze ovarian function, we performed transplantation using fresh or
cryopreserved immature grafts in pre-pubertal or adult mice. Puberty as well as cyclic hormonal activity was restored. All
follicle populations were present although a significant reduction in follicle density was observed with or without
cryopreservation. Although fertility was restored, the graft is of limited life span. Because ex vivo ovary manipulation and
cryopreservation procedure, the status of genomic imprinting was investigated. Methylation status of the H19 and Lit1
Imprinting Control Regions in kidney, muscle and tongue of offsprings from grafted mice does not show significant
alteration when compared to those of unoperated mice.
Conclusions/Significance: These results demonstrate that immature ovarian grafting can restore spontaneous puberty and
fertility. However, these data suggest that follicle depletion leads to premature ovarian failure. This study addresses the very
important epigenetics issue, and provides valuable information to the study of ovarian transplantation suggesting that
these procedures do not perturb normal epigenetics marks. These results are highly relevant to the reimplantation question
of immature cortex in women.
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Introduction
Malignant childhood cancers represent 1% of all cancers, which
means, for example, a pediatric cancer incidence in USA of 122
per million children [1] or in France 1800 new pediatric patients
each year (700 between 15 to 19 years old) [2]. In 1973, the five-
year survival rate after pediatric cancer was 50.4% [3]. Since
1990, progress in pharmacology has allowed a five-year survival
rate of nearly 75% [4]. Therefore in 2010, one young adult (15–
45 years old) in 250 to 715 will be a pediatric cancer survivor
[5,6]. However these therapeutical advances are associated with
long-term morbidities, especially regarding ovarian failure [7],
responsible for puberty delay [8] and infertility [9].
In adults, embryo freezing remains the best choice to preserve
fertility of women with a partner [10]. The other options are
oocyte cryopreservation or ovarian cortex cryopreservation [11],
before treatment [12]. In pre-pubertal girls, the alternative is the
cryopreservation of one ovary, a protocol currently proposed in
some countries to children before the sterilizing treatment [13].
Although births have been reported after reimplantation of either
cryopreserved [14–18] or fresh adult ovarian cortex [19–21], the
efficiency of pre-pubertal ovarian cortex for the restoration of
fertility and endocrine function is still unknown. Particularly, the
timing of reimplantation must deal with the major aim of this
strategy, i.e. restoration of fertility. However, induction of puberty
by early grafting should also be questioned. In animal models
(ewes, mice, rats, rabbits), the use of adult cryopreserved ovaries
has been largely reported and only two experiments describe the
reimplantation of fetal or neonatal ovarian cortex [22,23].
Another point of interest is the epigenetic changes in animals
conceived by assisted reproductive technologies (ART). In
particular, genomic imprinting refers to an epigenetic marking
of certain genes, resulting in monoallelic expression in a parent of
origin-dependent manner. Imprinted genes are characterized by
Differentially Methylated Regions (DMR). The allele specific
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in oocytes) and must be maintained during pre-implantation
development when the rest of the genome is subjected to a wave of
demethylation [24]. At the distal end of human chromosome 11p15.5
and mouse chromosome 7, two clusters of imprinted genes are under
the control of imprinting control regions (ICR). The H19-Igf2 region
is controlled by the H19 ICR, methylated on the paternal allele
[25,26]. The second adjacent cluster contains several maternally
expressed genes that include Cdknc1 and Kcnq1.T h i sr e g i o nh a r b o r sa
single paternally expressed gene Lit1 (or Kcnq1ot1) with a CpG island
called KvDMR1 which is methylated on the maternal chromosome
during oogenesis [27–29]. Aberrant genomic imprinting induces
numerous genetic disorders. As an example, patients with Beckwith-
Wiedemann Syndrome (BWS), linked to chromosome 11p15.5, have
abnormal hypermethylation of the maternal H19 ICR, leading to
higher expression of IGF2 with an overgrowth syndrome and
increased cancer risk [30–34]. A slight increase in imprinting
anomalies has also been reported in children conceived by assisted
reproductive technology with a higher incidence of BWS, Prader-
Willi or Angelman syndrome [35–40]. The epimutation reported in
BWS after ART involves a loss of methylation at the maternally
methylated KvDMR1 [36]. Because the H19-Igf2 and Lit1 regions
appear to be sensitive to external modifications [41,42], H19 ICR
and Lit1 KvDMR1 methylation were used in this study to evaluate
epigenetic changes in pups born after ovarian cryopreservation.
In this report, we performed orthotopic ovarian transplantation
using fresh and/or cryopreserved whole ovaries from non-pubescent
mice and demonstrated the efficiency of these immature (defined as
preserved before puberty) cryopreserved ovaries to restore both
endocrine function and fertility even in immature recipients. We also
focusedonthe methylationstatusoftheH19 ICR and Lit1 KvDMR1
from grafted mice and were able to show absence of significant
difference compared with non manipulated mice, suggesting that
cryopreservation and/or ovarian transplantation do not interfere
with proper establishment of genomic imprinting.
Methods
Animals
Mice of 129 Sv/J genetic background were housed under
normal laboratory conditions in a 12-h light, 12-h dark cycle
(0700–1900), in the animal facility of the Necker Faculty. The
temperature was controlled (21uC), and the animals had free
access to tap water and standard pelleted animal food. Immature
ovaries were obtained from mice operated before three weeks of
age at day 18 after birth (the regular age at puberty is of 5–
6 weeks). Recipients between three and four weeks were
considered as immature and after 2 months of age as adult mice.
All procedures were approved by the Necker Faculty Lab-Animal
Care and Use Committee. Controls groups contained non
manipulated animals and animals with unilateral ovariectomy.
Orthotopic ovarian transplantation
According to the groups defined in Table 1, 86 mice were
operated. Anesthesiology was performed with solution containing
150 ml of Xylazine (RompunH, Bayer Health Care), 600 mlo f
Ketamine (ImalgeneH100, Merial) and physiological injectable
serum (3 ml). Dose of 0.1 ml for 10 g of mice weight was injected
intra-peritoneally. Ovarian grafts were obtained by removal of one
entire ovary and placed in BrahmaH 1 solution (CryoBioSystem,
l’Aigle, France) to use freshly (n=51) or after cryopreservation
(n=35). Ovarian transplantation was performed by bilateral
posterior approach after removal of both ovaries from the bursa
surrounding ovaries and replacement of one entire ovary (fresh or
cryopreserved) near the oviduct, in the ovarian bursa [43]. Skin
was sutured after the operation. Surgery was performed under
Zeiss surgical microscope (Carl Zeiss, Oberikochen, Germany) at
room temperature. Intact ovary was either frozen within 30 min of
dissection or grafted into the ovarian bursa within 20 min of
dissection.
Ovarian cryopreservation
Ovaries were cryopreserved using the same protocol as described
by Gosden et al. [44]. Whole ovary tissue was equilibrated at 4uC for
30 min in cryogenic vials containing BrahmaH 1 solution with 10%
bovine calf serum and 1.5 M dimethylsulfoxide (DMSO). The vials
were transferred to a programmable freezer (Planner Products,
Cryobiosystem) and cooled at 2uC/min for seeding and followed by
0.3uC/min to 240uC and subsequently at 10uC/min to 2140uC.
Vials were stored in liquid nitrogen, for approximately 2 to 4 weeks.
Before grafting, tissues were rapidly warmed in air at room
temperature for 30 s and then immersed in water at 30–35uC for
5 minutes. The ovaries were removed from the cryovials and placed
successively in 4 solutions containing decreasing DMSO concen-
trations. After washing, ovaries were placed in Leibovitz-L15
Table 1. Groups of transplanted mice and cyclic hormonal activity.
Graft’s status Donor’s status Recipient’s status n Histology Fertility Recovery of cycle Length of cycle
NNF Fresh (F) Non mature (N) Non mature (N) 27 5 22 16.662.5 5.160.9
NAF Non mature (N) Adult (A) 16 4 12 17.563.3 4.561.0
AAF Adult (A) Adult (A) 15 7 8 15.662.0 5.261.1
NNC Cryopreserved (C) Non mature (N) Non mature (N) 11 3 8 10.260.4 5.460.8
NAC Non mature (N) Adult (A) 9 6 3 11.560.5 6.560.7
AAC Adult (A) Adult (A) 8 4 4 12.661.5 4.660.8
Total 86 29 57
Non-pubertal mouse, 18 day-old was defined as immature and grafted in non-mature (N) or adult mice (A), using cryopreserved (C) or fresh (F) graft. Grafted mice were
divided in two groups: mice sacrificed one month after grafting for histological study and the others mated with stud male, to study fertility. n, number of animals/
group used for analysis.
Recovery of cycle corresponded to the delay between transplantation and the vaginal opening in non mature recipients and to the delay between transplantation and
the recovery of cyclic activity in adult recipients. Length of cycle was defined as the delay in days between two estrus. Data are expressed in days, as mean6SEM.
doi:10.1371/journal.pone.0001972.t001
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thawing.
Evaluation of onset of puberty and estrous tracking
Female mice were observed daily, after ten days of grafting, for
appearance of vaginal opening. Once this occurred, daily
histological analysis of vaginal smears was taken. The vaginal
wall was washed using 20 ml of PBS and cells smeared onto a clean
glass slide. The stage of estrous cycle was determined from the cell
types observed in the vaginal smear [45]. Estrous cycle was
determined as the interval between onset of one estrous and the
next estrous event.
Breeding test
After recovery of cycle activity, 57 grafted mice were paired
with mature males of the same genetic background. Control group
comprised unilateral ovariectomized mice and WT mice. Vaginal
plugs were inspected daily. The date of birth and size of each litter
was recorded. When a female failed to produce a litter within
90 days of the initial mating, the male was replaced. If no litter or
visible signs of pregnancy (by daily weight increase) were observed
after three months of mating or last pregnancy, the female was
autopsied and examined for ovarian tissue.
A secondary NNF group of 10 mice was sacrificed 5.5 days after
the observation of the first plug. Implantation sites (IS) were
visualized by an i.v. injection (0.1 ml/mouse) of Chicago blue B
dye solution (1% in saline), and the number of ISs demarcated by
distinct blue bands was recorded.after injection of 0.1 ml of
Chicago Blue. Number of IS in uteri and corpora lutea by ovary
was counted then compared.
Histology and immunohistology
Early ovarian histology was obtained by sacrifice of 29 mice
from different groups 30 days after grafting. Removed ovaries
were placed in formalin then embedded in paraffin wax, serially
sectioned at 5 mm and stained with haematoxylin and eosin. The
sections were examined for the presence of follicles and corpora
lutea. Sections were also stained with periodic acid Schiff (PAS) for
apoptosis study. In same mice, proliferation was tested by
immunohistochemical staining of PCNA and vascularisation by
a-actin smooth muscle staining on 5 mm thick sections from
formalin-fixed, paraffin-embedded tissue blocks. Briefly, the
sections were de-paraffinized and boiled in microwave for
265 min in 0.01 M citrate buffer pH 6, then cooled to room
temperature for 30 min. For PCNA immunostaining, polyclonal
rat anti-mouse antibody (Santa Cruz biotechnology) was used at a
1:250 dilution. For a-actin smooth muscle staining, polyclonal
anti-mouse antibody (Sigma) was used at a 1:300 dilution.
Immunostaining with anti-3b-HSD was done at a dilution of
1:3000 [46]. DAKO TechMate
TM 500 Plus staining system was
used following the manufacturer’s instructions. Negative controls
were processed in parallel by replacing the primary antibody by
buffer.
Follicular density
In slides obtained from 29 mice sacrificed early, follicular
density was calculated by reporting the total number of follicles by
the surface unit [47]. Ovaries fixed in 4% buffered formaldehyde
and included in paraffin were serially sectioned at a thickness of
5 mm, then sections were stained and were examined serially for
the presence of follicles and corpora lutea by ovary. To avoid
counting follicles more than once, follicles were counted in the
section where the dark-staining nucleolus was seen within the
nucleus of the oocyte using the Lucia software. Results were
pooled by group type and compared to unmanipulated ovaries.
Results are expressed as number by surface unit.
Uterus macroscopical analysis and mammary gland
whole mount
Uteri and mammary glands from manipulated mice having
received immature cortex in pre-pubertal or adult recipients were
analyzed one month after grafting or during pregnancy (mammary
gland), and compared with non-pubertal unmanipulated mice.
Inguinal mammary glands for whole-mount analysis were spread
on a glass slide and fixed overnight in 25% acetic acid/75%
ethanol. The samples were washed in 70% ethanol and stained
overnight in carmine (Sigma-Aldrich), dehydrated in ethanol and
xylene, and mounted with coverslip.
Methylation status of H19 ICR and Lit1 KvDMR1 in pups
issued from grafted mice
Epigenetic status was studied in pups from grafted mice,
included in the six groups previously described and in mice issued
from non manipulated mice, by collecting kidney, muscle and
tongue at 21 days of age. The methylation status of these H19 ICR
was followed at early stages after birth by analyzing nine
unmanipulated mice sacrificed at 5, 10 and 15 days of life.
Genomic DNA was prepared from tissues by standard
proteinase K digestion and phenol–chloroform extraction meth-
ods. For H19 ICR, genomic DNA from each sample was digested
with Sac1 and the methylation-sensitive enzyme Hha1, separated
on 1% agarose gel, transferred to Hybond N+ (GE Healthcare) in
0.4 M NaOH and hybridized to the CTCF3 specific probe. The
probe was obtained by PCR with sense primer: 59ctgttatgtgcaa-
caagggaa and anti-sense primer: 59ggtcttaccagccactga. The upper
band (3.8 kb) is methylated and corresponds to the paternal allele.
The lower band (0.3 kb) is unmethylated and corresponds to the
maternal allele. Methylation indexes were determined by densi-
tometry of autoradiographs using a Storm PhosphoImager
(Molecular Dynamics, Sunnyvale, USA). Results were expressed
as the ratio (MI) between fragment intensity of the upper
methylated band compared to the sum of fragment intensity of
upper band and lower unmethylated band. In physiological status,
MI is of 0.5.
For Lit1 KvDMR1, genomic DNA was digested with Apa1 and
the methylation-sensitive enzyme Sma1 and probed with a
KvDMR1 fragment obtained by PCR using sense primer:
59cactggagctgaaaccgaatcg and anti-sense primer: 59aaaacaggtgca-
gaaatgg. A maternal methylated 2.6 kb fragment and a paternal
0.9 kb unmethylated fragment were detected for this DMR.
Statistical analysis
Statview software was used for statistical analysis. ANOVA
(multiple comparisons) was used. The significance was set at
p,0.05, and the values were presented as mean6SEM as
specified.
Results
Onset of puberty and restoration of hormonal activity
A total of 86 female mice successfully underwent orthotopic
ovarian transplantation. In 63 animals ovarian grafts originated
from mice of less than three weeks of age considered as immature
donor mice (pre-pubertal). Fresh (F) (n=43) or cryopreserved (C)
(n=20) immature ovarian grafts were transplanted either in non
mature (N) (n=38) or in adult (A) (n=25) mice. The control group
Immature Ovary Transplantation
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(n=8) adult ovarian grafts (Table 1). After surgery, the occurrence
of vaginal opening and onset of estrus cycle were observed as an
external indicator of functional graft in all groups (Table 1). When
the recipient was pre-pubertal at time of grafting, occurrence of
cycle was considered as the sign of pubertal instauration. The
study of estrus cycle was tracked by analysis of vaginal cytology for
a period of 21 days. The mean age of puberty onset occurred
between 5 and 6 weeks of age in immature grafted mice as well as
in unoperated control mice. Recovery of hormonal activity
occurred after 14.962.8 days, without any statistical difference
between groups. In particular, no difference was observed between
the groups of transplanting immature ovaries to immature animals
(NNF and NNC) and immature ovaries to adult animals (NAF and
NAC) as well as in immature ovaries to adult animals (NAF and
NAC) compared to adult ovaries to adult animals (AAF and AAC).
Data indicated that length of estrous cycle was similar whatever
the age of donor and recipient and the status of graft (fresh or
cryopreserved) corresponding to a number of 4–5 estrous cycles
during this experimental period.
Ovarian histology
Examination of ovaries after one month of grafting showed the
presence of follicles at all developmental stages and corpora lutea
(CL) in all groups (Figure 1). The presence of CL indicated that
ovulation had occurred. Macroscopic analysis of the whole graft
showed the re-establishment of a network of blood vessels
demonstrating that revascularization of the graft took place in all
analyzed groups, as assessed by the presence of capillaries.
Immunostaining using a-actin smooth muscle antibody, a marker
for blood perivascular smooth muscle cells, also attested the
presence of vascularisation in layers surrounding the granulosa
cells. In larger follicles, this layer became hyperemic and
numerous small blood vessels could be seen as well as some
stromal vessels in the medullary region of transplanted ovary
(Figure 1). Analysis of the proliferation rate of follicular cells by
PCNA immunostaining in follicles demonstrated active prolifera-
tion in all experimental groups. Proliferation was not modified by
the age of donors, neither by the process of cryopreservation.
Moreover, apoptosis of follicles analyzed by PAS staining
demonstrated a similar pattern of cellular death in all groups
(Figure 2).
Follicular density
After transplantation into unmanipulated recipient mice, the
ovaries developed many preantral, antral follicles and corpora
lutea. The evaluation of follicular density showed no difference
between groups of mice receiving immature grafts but was
significantly decreased as compared to unmanipulated control
mice (16.14 versus 38 follicles/mm
2) (Figure 3). The follicular loss
was thus clearly linked to grafting related ischemia rather than
cryopreservation process or recipient age. The mean number of
corpora lutea by group was also significantly decreased as
compared with unmanipulated mice.
Breeding tests and size of litters
Daily observations of mice revealed that 100% of the
transplanted (n=57) and unmanipulated control mice (n=15)
mated, as indicated by the appearance of vaginal plugs, a sign of
normal sexual behavior. After a normal length of pregnancy, 25 to
50% of grafted mice gave birth to offspring (Table 2). Mean
number of gestations by mouse during the observation period was
between 1.5 and 2.5 in all mice receiving immature ovary. The last
gestation occurred between 3 and 8.75 months after grafting. This
is very early in lifespan and statistically significant (p,0.005) when
compared to the mean length of reproductive life in unmanipu-
lated control mice. These results indicate that the transplantation
process, even with immature ovaries, induces premature ovarian
failure. In all manipulated groups, the mean litter size was
significantly decreased compared to unmanipulated control mice
(2.060.5 versus 9.160.6 pups) (Figure 4). Since reimplantation
was done with only one ovary, a new control group of mice
undergoing unilateral ovariectomy was generated and this group
gave rise to a litter size similar to unmanipulated control mice.
Comparison of grafted groups with both control groups (unma-
nipulated and unilaterally ovariectomized) was thus significantly
different (Figure 4).
In NNF group of mice sacrificed 5.5 days after the appearance
of the plug, a significant difference existed between the number of
implantation sites (0.860.32 by mouse) and the number of corpora
lutea seen in the ovary (5.560.74 by ovary) suggesting a failure of
early implantation.
Out of 57 grafted females exhibiting a plug, only 21 gave birth
to pups. In order to understand the absence of pregnancy in the 36
remaining mice, we performed an autopsy after three months of
infertility. In 44% of infertile mice (16/36), ovaries were
macroscopically and histologically normal. In other cases, we
found a regression of transplants in 36% of cases (13/36) as well as
misallocation of the transplanted tissue outside bursa ovary in 19%
Figure 1. Histological analysis of ovary after one month of
grafting and vascularization analysis. Immature ovarian cortex
was grafted in non-pubertal mice freshly (NNF) either after cryopres-
ervation (NNC) or in adult mice freshly (NAF) or after cryopreservation
(NAC). Corpus luteum (CL) signs ovulation process. All images are at the
same magnification. Representative slide of one ovary from NNC group
is shown after immunohistochemical detection of vascularization using
a-actin smooth muscle antibody as compared with control (without
primary antibody). Scale bar, 100 mm
doi:10.1371/journal.pone.0001972.g001
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excluding mice with an anatomical cause of failure (20/36) and
was found to be between 40 and 80%.
Uterine and mammary gland whole mount assessment
The macroscopical aspect of the uterus in NNF mice after onset
of puberty was similar to the one observed in adult unmanipulated
mice and significantly different from pre-pubertal unmanipulated
control mice (Figure 5). This demonstrated the efficiency of grafted
ovaries to synthesize steroids for uterus impregnation. Whole-
mount analysis of mammary glands in grafted mice showed
normal ducts and small terminal end buds, similar to those
observed in pubertal unmanipulated control mice as well as
normal development of the mammary gland during the second
half of gestation (Figure 5).
Analysis of long-term follicle depletion
In transplanted mice, analysis of ovarian graft after the last
gestation showed complete follicular depletion in all cases (Figure 6)
with follicular impairment and numerous scarses resulting from
follicular death and remnants of oocytes that have undergone
atresia. Overall analysis showed the presence of interstitial cells
with a steroidogenic appearance without any granulosa cells.
Moreover, to evaluate the steroidogenesis ovarian sections were
assessed by immunohistochemistry with P450scc, 3b-HSD and
P450 C17 antibodies. In all groups 3b2HSD enzyme was
detected in about 50% of the interstitial cells suggesting that
steroidogenesis was still present (Figure 6).
Methylation status of H19 ICR and Lit1 KvDMR1 in pups
from grafted mice
Three different tissues were collected in 76 pups from grafted
mice as well as in 52 unmanipulated pups representing the control
group. Southern blotting of SacI/HhaI digested DNA followed by
hybridization with an H19 internal probe, allowed detection of an
unmethylated maternal allele (0.3 kb) and a methylated paternal
allele (3.8 kb) (Figure 7A). The methylation index (MI: methylated
fragment/unmethylated + methylated fragment) was analyzed at
5, 10, 15 and 21 days after birth in kidney, muscle and tongue
from control mice and no significant difference was found in
control mice between these different time points (data not shown).
The global methylation status of the three tissues was then
evaluated in manipulated samples taken at 21 days and compared
to control samples. A slight difference was observed between
muscle and tongue DNA methylation (MI.0.6) compared to
kidney DNA (MI=0.5). The same significant difference appeared
Figure 2.Follicular proliferation and apoptosis. Cell proliferation was studied using PCNA antibody and apoptosis using PAS staining one
month after grafting. Immature ovarian cortex was grafted in non-mature mice freshly (NNF) or after cryopreservation (NNC) or in adult mice freshly
(NNF) or after cryopreservation (NNC). All images are at the same magnification. Scale bar, 50 mm
doi:10.1371/journal.pone.0001972.g002
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no significant difference was detected in all studied groups
whatever their origin (Figure 7C). In particular, no variation was
seen in pups from grafted mice receiving immature or adult
ovaries nor fresh or cryopreserved ovaries. In addition to the H19
ICR, we evaluated the methylation status of the maternally
methylated Lit1 KvDMR1. A similar analysis was performed using
SmaI-ApaI digested DNA (0.9 kb paternal and 2.6 kb maternal
fragments) hybridized with a Lit1 internal probe, on a more limited
number of samples (Figure 7D). Again, a difference was observed
between different tissues with a higher methylation index in the
tongue compared to muscle and kidney. However, the global
methylation status of the same three tissues showed no significant
difference in all studied groups whatever their origin (Figure 7E).
Discussion
In women, cancer therapy (chemo and radiotherapy) or
myeloablative treatment required for stem cell transplantation
before puberty may lead to a precocious ovarian failure. Today,
the only option to avoid this detrimental side effect is ovarian
cryopreservation of cortex slices from one ovary before treatment.
Although the feasibility of surgery [48] and of techniques of ovary
cryopreservation have been well documented, reimplantation of
ovaries cryopreserved before puberty has not been performed in
non pubertal recipients humans nor in animal models. As ovarian
tissue banking in pediatric clinical practice is an ongoing process in
some countries [13,49], this represents potential benefit for
patients at high risk of infertility. It is thus mandatory to define
the optimal modalities of reimplantation for these immature
ovarian cortexes. Results in adults in term of pregnancy remain
promising, with four births of normal babies using cryopreserved
ovaries [14,15,17,18] and six pregnancies using fresh cortex [19–
21]. The first report of pregnancy in a patient treated for
Hodkgin’s lymphoma had raised polemics on the authenticity of
complete ovarian failure [50–52] and the possibility of spontane-
ous pregnancy in one such patient [53]. Another spontaneous
pregnancy has been described in a patient treated for Hodgkin’s
disease after heterotopic reimplantation of cryopreserved ovarian
cortex [54]. Our report is focused on the specific problem of
pediatric patients as the few publications dealing with immature
ovaries in mice only reported on the status of the primordial
follicle pool [22,55].
By using adult grafts, we confirm the results previously reported
by others for fertility [56]. However, we demonstrate that the
fertility of ovariectomized non-pubertal recipient can be restored
by grafting immature ovaries capable of ovulation whatever the
age of the recipient and the graft status (fresh or cryopreserved).
These results may be explained by the high density of primordial
follicles in ovarian cortex taken from young donors, as they are
known to better withstand cryopreservation than more developed
follicles [57]. Our results support the current clinical protocol
which promotes ovarian cryopreservation in young girls undergo-
ing sterilizing treatment before puberty.
Taking into account endocrine function, our model demon-
strates that spontaneous puberty occurred when ovarian reim-
plantation was performed before puberty. A rescued cyclical
Figure 3.Follicle density and number of corpora lutea by ovary
in each group one month after grafting. n=5 mice/group. Data
are expressed as mean density6SEM. The asterisks indicate significant
differences between groups of manipulated mice and unmanipulated
mice (control) (p,0.001)
doi:10.1371/journal.pone.0001972.g003
Table 2. Litter sizes following the first, second and third pregnancies, in each group and secondary infertility.
1st pregnancy 2nd pregnancy 3rd pregnancy Secondary Infertility
Vaginal plug Litter size %/all Litter size %/all Litter size %/all
NNF 22/22 1.760.2 36% 1.660.3 13.3% 1.0 4.5% 5.562.1
NNC 12/12 1.060 33% 1.660.3 25% 2.061 16.6% 5.761.3
NAF 8/8 4.063.0 25% 1.0 12.5% - - 3.061.7
NAC 8/8 1.560.5 50% 5.060.5 37.5% 1.0 12.5% 8.762.6
AAC 4/4 1.560.5 50% 2.0 25% 2.0 25% 5.562.0
AAF 3/3 5.0 33% 1.0 33% 1.0 33% 8.0
WT 15/15 9.160.6 100% 9.460.8 100% 9.061 100% .18
Vaginal plug, number of mice after mating/number of studied mice, by group. %/all, pregnancy rate of females mated. Litter size: mean of pups by female. Secondary
infertility was defined as the date, in months after grafting of the ultimate gestation. All data are expressed as mean6SEM.
doi:10.1371/journal.pone.0001972.t002
Immature Ovary Transplantation
PLoS ONE | www.plosone.org 6 April 2008 | Volume 3 | Issue 4 | e1972hormonal activity was also observed when the recipients were
young adults. Puberty induction has never been explored in
animal models nor discussed in humans since hormonal
substitution is available [58]. The risks of a long-term hormonal
treatment initiated very early in life remain however undefined
particularly in children who have an increased risk of secondary
neoplasia. This higher risk is linked both to the potential genetic
predisposition that may have given rise to the initial tumor and/or
to the treatment received [59]. Using immature ovarian mouse
grafts, even after cryopreservation and reimplantation before
puberty (NNC group), we show that it is possible to induce puberty
which in addition begins at a normal age. Reimplantation of
immature cryopreserved cortex could thus be proposed to pre-
pubertal girls to induce natural puberty but only if the tissue
should be able to support long-term hormonal secretion and to
assure fertility. Because all data indicate that the reproductive
lifespan of grafted ovarian tissue in humans [60,61] is limited, the
main target of ovarian grafting is restoration of fertility and should
therefore only be considered when relevant in this respect.
It is known that ovarian grafting, even without cryopreservation
[62], induces a dramatic follicular loss (65%), whatever the age of
donors and recipients (adult-adult or pre pubertal-adults [22]) or
the location of graft (orthotopic or under kidney capsule [63]).
This has also been reported in sheep [64] and in few cases of re-
implanted cryopreserved human ovaries [65]. Our results confirm
these data showing a 50% reduction of follicle density after
transplantation independently of cryopreservation process and
experimental group. Follicular loss may be related to the ischemia
induced by the harvesting procedure and the prolonged delay of
the neovascularisation following reimplantation [14]. Alternative-
ly, a disruption of the granulosa-oocyte crosstalk, potentially
induced by the procedure has been proposed [66]. The only
models reporting no follicular loss used mouse fetal ovaries
Figure 5. Representative macroscopic images of the uteri and
mammary gland. Uterus of non-mature unmanipulated mouse is
compared to those of non-pubertal mouse grafted with immature
cortex (NNC), two months after transplantation and of pubertal mice
grafted with immature cortex (NAC), six months after transplantation.
All images are at the same magnification. Scale bar, 1 cm. Represen-
tative whole mount of mammary glands from non mature mouse is
compared to the mammary gland from a pre-pubertal mouse grafted
with immature cortex (NNC) at mid pregnancy.
doi:10.1371/journal.pone.0001972.g005
Figure 6. Representative histological and immunohistochem-
ical analysis for 3 b-HSD of ovaries at one year after grafting.
Mice were grafted with fresh (NNF, NAF) or cryopreserved (NAC)
immature cortex ovaries. Recipients were non-mature (NNF) or adult
mice (NAF and NAC). Scales bar 100 mm.
doi:10.1371/journal.pone.0001972.g006
Figure 4. Number of pups by litter in each group. Size of the litter
was recorded in each group as compared to unmanipulated mice
(control) and to mice after unilateral ovariectomy (Ovx). The asterisks
indicate significant differences (p,0.001) between manipulated groups
and control groups. All data are expressed as mean6SEM.
doi:10.1371/journal.pone.0001972.g004
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resistant to cryopreservation. The ischemia-related loss of the
follicular population may account, in a large part, for the
premature ovarian failure. Whereas immature ovaries contain a
high pool of primordial follicles as compared to the adult ovaries,
no gestation after 35 weeks of grafting was observed in our mouse
model due to a complete depletion of follicles associated however
to active steroidogenesis in interstitial cells. The interstitial cells are
probably more protected from post grafting ischemia than the
avascular granulosa cells, which rely on diffusion of oxygen and
Figure 7. Methylation status of H19 ICR and Lit1 KvDMR1. (A) H19 ICR methylation was determined by Southern blotting after digestion with
Sac I (S) and Hha1 (H) enzymes. The upper band (3.8 kb) corresponds to the paternal methylated allele (P) and the lower band (0.3 kb) corresponds to
the maternal unmethylated allele (M). Probe is marked by thick black line. (B) H19 ICR methylation was analyzed in DNA from three tissues: kidney
(Ki), muscle (Mu), and tongue (To) in unmanipulated (white) or grafted animals (black). ***, p,0.001 for kidney compared to both other groups
(muscle and tongue) (C) H19 ICR ratio was represented in unmanipulated (control, white) or grafted animals (black) in three tissues according to the
manipulated group. (D) Lit1 KvDMR1 methylation was determined by Southern blotting after digestion with Sma I (Sm) and Apa I (Ap) enzymes. The
upper band (2.6 kb) corresponds to the maternal methylated allele (M) and the lower band (0.9 kb) corresponds to the paternal unmethylated allele
(P). Probe is marked by thick black line. (E) Lit 1 KvDMR1 ratio was compared in muscle (Mu) and tongue (To) from unmanipulated (white bar) or
grafted animals (black bar). ***, p,0.001 for tongue vs muscle.
doi:10.1371/journal.pone.0001972.g007
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models, to our best knowledge it is the first report that reveals the
notion of premature failure of ovarian grafts in mice [64]. These
data have to be considered to define the optimal period for
reimplantation in young patients and exclude the use of the
cryopreserved cortex for puberty initiation, favoring its consump-
tion for pregnancy wishes.
Contrasting data have been reported on litter size, some authors
describing normal [23,68] whereas others suggest smaller litter
sizes [69] similar to the results obtained in our study. Several
reasons could be put forth to explain the decrease of pup number:
decrease in the number of implantation sites related to reduced
follicle recruitment per cycle or a misallocation of the ovarian graft
or prenatal fetal loss. The unilateral graft could not be
incriminated since there is no difference in litter size between
unilateral ovariectomized mice and unmanipulated control
groups. The number of implantation sites at day 5.5 of pregnancy
as compared with the number of corpora lutea by ovary in the
NNF group was significantly reduced suggesting a defect of
embryo implantation. The risk of fetal loss because of malforma-
tions potentially related to epigenetic changes is a very important
notion in view of treatment of human patients. Although
epigenetic abnormalities in mice after assisted reproductive
technologies have not been reported, (probably because such
malformations lead to abortion), such abnormalities have been
described after assisted reproductive technology in sheep [70]. Due
to the increased frequency of developmental impairment such as
BWS or Angelman syndrome [35,36,40,71] or tumors such as
retinoblastoma [31] in children born after ART (ovarian
stimulation, in vitro fertilization and/or in vitro maturation of
oocytes), this point should be discussed along with ovarian
cryopreservation. The use of immature ovaries could increase this
risk since the process occurs before the full establishment of
imprinting in mature oocytes [34,72].
Two DMRs from imprinted genes were analyzed, the paternally
methylated H19 DMR and the maternally methylated Lit1
KvDMR1. Although the H19 DMR is methylated in the male
germline, this DMR was chosen because H19 belongs to the
cluster of genes affected in BWS. A second reason stems from the
hypothesis that the maternally derived DMR must be protected
from remethylation during the first stages of embryo development
[73]. This protection could have been affected by the transplan-
tation or cryopreservation of the immature ovaries. The Lit1
KvDMR1 was analyzed because it clearly acquires its methyla-
tion through the female germline [74]. Interestingly, the
methylation indexes in several tissues showed that the methyla-
tion profile of both DMRs is constant within an organ but varies
significantly between tissues, i.e. muscle and tongue versus kidney
for the H19 DMR or muscle versus tongue for the KvDMR1.
However, no significant difference was found between pups born
from grafted ovarian or control females, independently of the
graft status (fresh or cryopreserved) or of the age of recipients and
donors. This strongly suggests that immature ovaries transplanted
into immature or adult recipient females can produce oocytes
which harbor a correct imprinting of at least the two H19 and
LIT1 genes. These data should probably be taken with caution
because of the relatively small number of samples. Furthermore,
the reduced litter size observed in the cases of manipulated
females could reflect spontaneous abortions due to malformations
linked with imprinted genes. This is nevertheless an encouraging
result.
In conclusion, our model supports the legitimacy to propose
cryopreservation in young girls before gonadotoxic treatment as a
tool to restore fertility, as has been done in adult women.
Regarding our current knowledge concerning this procedure, one
should remain cautious when delivering information to patients
and their family at the time of cryopreservation, in terms of
puberty induction and potential risks for children.
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